• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝胆 MRI 对比剂:儿科局灶性肝脏病变的模式识别方法。

Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.

机构信息

Department of Radiology, Duke University Medical Center, Durham, NC.

Present address: Department of Radiology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, TX 75390.

出版信息

AJR Am J Roentgenol. 2020 May;214(5):976-986. doi: 10.2214/AJR.19.22239. Epub 2020 Mar 17.

DOI:10.2214/AJR.19.22239
PMID:32182093
Abstract

The purposes of this article are to review currently available hepatobiliary contrast agents, discuss techniques for optimization of pediatric liver MRI with hepatobiliary contrast agents, and review the imaging features of several pediatric hepatic lesions, focusing on their assessment with hepatobiliary contrast agents. MRI is the preferred imaging modality for complete assessment of focal liver lesions in the pediatric population. Imaging with gadolinium-based hepatobiliary contrast agents yields beneficial information about many focal liver lesions encountered in pediatric patients.

摘要

本文旨在回顾目前可用的肝胆对比剂,讨论优化小儿肝脏 MRI 与肝胆对比剂的技术,并复习几种小儿肝脏病变的影像学特征,重点是评估这些病变应用肝胆对比剂的情况。磁共振成像(MRI)是小儿局灶性肝脏病变全面评估的首选影像学方法。钆基肝胆对比剂的成像可为小儿患者中遇到的许多局灶性肝脏病变提供有益的信息。

相似文献

1
Hepatobiliary MRI Contrast Agents: Pattern Recognition Approach to Pediatric Focal Hepatic Lesions.肝胆 MRI 对比剂:儿科局灶性肝脏病变的模式识别方法。
AJR Am J Roentgenol. 2020 May;214(5):976-986. doi: 10.2214/AJR.19.22239. Epub 2020 Mar 17.
2
A Pictorial Review of Hepatobiliary Magnetic Resonance Imaging With Hepatocyte-Specific Contrast Agents: Uses, Findings, and Pitfalls of Gadoxetate Disodium and Gadobenate Dimeglumine.肝细胞特异性对比剂在肝胆磁共振成像中的图谱综述:钆塞酸二钠和钆贝葡胺的用途、表现及陷阱
Can Assoc Radiol J. 2017 Aug;68(3):293-307. doi: 10.1016/j.carj.2016.10.008. Epub 2017 Jun 2.
3
Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications.用于肝脏对比增强磁共振成像的肝胆对比剂:特性、临床研发与应用
Eur Radiol. 2004 Apr;14(4):559-78. doi: 10.1007/s00330-004-2236-1. Epub 2004 Feb 25.
4
Inflammatory hepatic adenomas: Characterization with hepatobiliary MRI contrast agents.炎症性肝腺瘤:使用肝胆磁共振成像造影剂的特征分析
Magn Reson Imaging. 2018 Apr;47:103-110. doi: 10.1016/j.mri.2017.12.006. Epub 2017 Dec 5.
5
Hepatobiliary MR imaging with gadolinium-based contrast agents.肝胆系统磁共振成像中的钆对比剂应用。
J Magn Reson Imaging. 2012 Mar;35(3):492-511. doi: 10.1002/jmri.22833.
6
[Magnetic resonance imaging of the liver: what kind of contrast agents?].[肝脏的磁共振成像:使用何种造影剂?]
Radiol Med. 2001 Sep;102(3):109-21.
7
Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.肝脏局灶性病变的磁共振成像:影像诊断方法。
Hepatology. 2011 Dec;54(6):2227-37. doi: 10.1002/hep.24679.
8
Hepatobiliary-specific MR contrast agents: role in imaging the liver and biliary tree.肝胆特异性磁共振对比剂:在肝脏和胆道成像中的作用。
Radiographics. 2009 Oct;29(6):1725-48. doi: 10.1148/rg.296095515.
9
[Current status of MRI diagnostics with liver-specific contrast agents. Gd-EOB-DTPA and Gd-BOPTA].[肝脏特异性对比剂的磁共振成像诊断现状。钆塞酸二钠和钆贝葡胺]
Radiologe. 2004 Dec;44(12):1185-91. doi: 10.1007/s00117-004-1134-5.
10
The MR imaging diagnosis of liver diseases using gadoxetic acid: emphasis on hepatobiliary phase.钆塞酸二钠在肝脏疾病磁共振成像诊断中的应用:重点在肝胆期。
Clin Mol Hepatol. 2013 Dec;19(4):360-6. doi: 10.3350/cmh.2013.19.4.360. Epub 2013 Dec 28.

引用本文的文献

1
White paper on the current state of imaging biomarkers in paediatric oncology.儿科肿瘤学中影像生物标志物现状白皮书。
Pediatr Radiol. 2025 Sep 2. doi: 10.1007/s00247-025-06372-6.
2
Recent Advances in Magnetic Resonance Imaging for the Diagnosis of Liver Cancer: A Comprehensive Review.磁共振成像在肝癌诊断中的最新进展:综述
Diagnostics (Basel). 2025 Aug 12;15(16):2016. doi: 10.3390/diagnostics15162016.
3
Can Dynamic Contrast-Enhanced MRI Be Used to Differentiate Hepatic Hemangioma from Other Lesions in Early Infancy?
动态对比增强磁共振成像能否用于鉴别早期婴儿期肝血管瘤与其他病变?
Indian J Radiol Imaging. 2024 Apr 21;34(4):612-619. doi: 10.1055/s-0044-1785208. eCollection 2024 Oct.
4
Contrast enhanced ultrasound of liver lesions in patients treated for childhood malignancies.儿童恶性肿瘤治疗后肝脏病变的超声造影表现
Cancer Imaging. 2024 Aug 29;24(1):115. doi: 10.1186/s40644-024-00750-3.
5
Better 90 Minutes Late than Never: Differential Diagnosis on MRI Scanning in a Case of Hepatic Angiosarcoma.迟来90分钟总比不来好:肝血管肉瘤一例的MRI扫描鉴别诊断
Life (Basel). 2024 Jun 28;14(7):823. doi: 10.3390/life14070823.
6
[Developmental disorders of the gastrointestinal tract].[胃肠道发育障碍]
Radiologie (Heidelb). 2024 May;64(5):392-399. doi: 10.1007/s00117-024-01302-3. Epub 2024 Apr 10.
7
Focal fatty sparing areas of the pediatric steatotic liver: pseudolesions on hepatobiliary phase magnetic resonance images.小儿脂肪肝的局灶性脂肪保留区:肝胆期磁共振图像上的假性病变。
Diagn Interv Radiol. 2024 Mar 6;30(2):135-138. doi: 10.4274/dir.2023.232447. Epub 2023 Nov 30.
8
Incidental Findings in Pediatric Patients: How to Manage Liver Incidentaloma in Pediatric Patients.儿科患者的偶然发现:如何处理儿科患者的肝脏偶然瘤
Cancers (Basel). 2023 Apr 18;15(8):2360. doi: 10.3390/cancers15082360.
9
Clinical prospective study of Gallium 68 (Ga)-labeled fibroblast-activation protein inhibitor PET/CT in the diagnosis of biliary tract carcinoma.镓 68(Ga)标记成纤维细胞激活蛋白抑制剂 PET/CT 临床前瞻性研究在胆道癌诊断中的应用。
Eur J Nucl Med Mol Imaging. 2023 Jun;50(7):2152-2166. doi: 10.1007/s00259-023-06137-z. Epub 2023 Feb 21.